U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H15O4P
Molecular Weight 278.2403
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIBENZYLPHOSPHORIC ACID

SMILES

OP(=O)(OCC1=CC=CC=C1)OCC2=CC=CC=C2

InChI

InChIKey=HDFFVHSMHLDSLO-UHFFFAOYSA-N
InChI=1S/C14H15O4P/c15-19(16,17-11-13-7-3-1-4-8-13)18-12-14-9-5-2-6-10-14/h1-10H,11-12H2,(H,15,16)

HIDE SMILES / InChI

Approval Year

Unknown
139594
PubMed

PubMed

TitleDatePubMed
Biosynthetic studies on the alpha-glucosidase inhibitor acarbose: the chemical synthesis of dTDP-4-amino-4,6-dideoxy-alpha-D-glucose.
2002 Feb 18
Synthesis of phosphate derivatives related to the glycosidase inhibitor salacinol.
2007 Sep 3
Name Type Language
DIBENZYLPHOSPHORIC ACID
Systematic Name English
DIBENZYL HYDROGEN PHOSPHATE
Systematic Name English
PHOSPHORIC ACID, BIS(PHENYLMETHYL) ESTER
Systematic Name English
PHOSPHORIC ACID, DIBENZYL ESTER
Systematic Name English
DIBENZYL PHOSPHATE
Systematic Name English
BENZYL PHOSPHATE, OP(OCH2PH)2OH
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
216-602-3
Created by admin on Sat Dec 16 08:09:20 GMT 2023 , Edited by admin on Sat Dec 16 08:09:20 GMT 2023
PRIMARY
CAS
1623-08-1
Created by admin on Sat Dec 16 08:09:20 GMT 2023 , Edited by admin on Sat Dec 16 08:09:20 GMT 2023
PRIMARY
EPA CompTox
DTXSID1033402
Created by admin on Sat Dec 16 08:09:20 GMT 2023 , Edited by admin on Sat Dec 16 08:09:20 GMT 2023
PRIMARY
PUBCHEM
74189
Created by admin on Sat Dec 16 08:09:20 GMT 2023 , Edited by admin on Sat Dec 16 08:09:20 GMT 2023
PRIMARY
FDA UNII
Y65R35LZ0S
Created by admin on Sat Dec 16 08:09:20 GMT 2023 , Edited by admin on Sat Dec 16 08:09:20 GMT 2023
PRIMARY
SALT/SOLVATE (PARENT)
Structure of AMMONIUM DIBENZYL PHOSPHATE
SALT/SOLVATE (PARENT)
Structure of SODIUM DIBENZYL PHOSPHATE
SALT/SOLVATE (PARENT)
Structure of SILVER DIBENZYL PHOSPHATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966